Abeona Therapeutics Stock Price History
| ABEO Stock | USD 7.53 0.40 5.04% |
Below is the normalized historical share price chart for Abeona Therapeutics extending back to September 19, 1980. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Abeona Therapeutics stands at 7.53, as last reported on the 19th of April, with the highest price reaching 8.17 and the lowest price hitting 7.51 during the day.
If you're considering investing in Abeona Stock, it is important to understand the factors that can impact its price. Abeona Therapeutics appears to be slightly risky, given 3 months investment horizon. Abeona Therapeutics secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of standard deviation over the last 3 months. By analyzing Abeona Therapeutics' technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please makes use of Abeona Therapeutics' risk adjusted performance of 0.0879, and Mean Deviation of 4.07 to double-check if our risk estimates are consistent with your expectations.
At this time, Abeona Therapeutics' Stock Based Compensation is very stable compared to the past year. As of the 19th of April 2024, Issuance Of Capital Stock is likely to grow to about 45 M, while Liabilities And Stockholders Equity is likely to drop about 49.3 M. . At this time, Abeona Therapeutics' Price Book Value Ratio is very stable compared to the past year. As of the 19th of April 2024, Price Earnings To Growth Ratio is likely to grow to 0.06, while Price To Sales Ratio is likely to drop 29.07. Abeona Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of September 1980 | 200 Day MA 5.0075 | 50 Day MA 7.2982 | Beta 1.479 |
Abeona |
Sharpe Ratio = 0.1376
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ABEO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.72 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Abeona Therapeutics is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abeona Therapeutics by adding it to a well-diversified portfolio.
Price Book 13.9303 | Enterprise Value Ebitda (3.16) | Price Sales 59.0086 | Shares Float 19.1 M | Wall Street Target Price 21 |
Abeona Therapeutics Stock Price History Chart
There are several ways to analyze Abeona Stock price data. The simplest method is using a basic Abeona candlestick price chart, which shows Abeona Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 6, 2024 | 8.68 |
| Lowest Price | January 31, 2024 | 4.07 |
Abeona Therapeutics April 19, 2024 Stock Price Synopsis
Various analyses of Abeona Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Abeona Stock. It can be used to describe the percentage change in the price of Abeona Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Abeona Stock.| Abeona Therapeutics Price Daily Balance Of Power | (0.61) | |
| Abeona Therapeutics Price Action Indicator | (0.51) | |
| Abeona Therapeutics Price Rate Of Daily Change | 0.95 |
Abeona Therapeutics April 19, 2024 Stock Price Analysis
Abeona Stock Price History Data
The price series of Abeona Therapeutics for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 has a statistical range of 4.61 with a coefficient of variation of 19.88. The prices are distributed with arithmetic mean of 6.72. The median price for the last 90 days is 7.35. The company had 1:25 stock split on 5th of July 2022.| Open | High | Low | Close | Volume | ||
04/19/2024 | 7.95 | 8.17 | 7.51 | 7.53 | ||
| 04/18/2024 | 7.95 | 8.17 | 7.51 | 7.53 | 245,958 | |
| 04/17/2024 | 7.76 | 8.45 | 7.73 | 7.93 | 729,644 | |
| 04/16/2024 | 7.60 | 7.89 | 7.53 | 7.76 | 218,566 | |
| 04/15/2024 | 7.56 | 7.69 | 7.44 | 7.64 | 113,688 | |
| 04/12/2024 | 7.69 | 7.84 | 7.43 | 7.55 | 188,039 | |
| 04/11/2024 | 7.35 | 7.84 | 7.32 | 7.79 | 173,527 | |
| 04/10/2024 | 7.23 | 7.37 | 7.06 | 7.36 | 160,761 | |
| 04/09/2024 | 7.53 | 7.68 | 7.18 | 7.44 | 128,401 | |
| 04/08/2024 | 7.39 | 7.57 | 7.12 | 7.52 | 209,704 | |
| 04/05/2024 | 7.64 | 7.82 | 7.32 | 7.44 | 218,315 | |
| 04/04/2024 | 8.05 | 8.28 | 7.62 | 7.70 | 173,226 | |
| 04/03/2024 | 7.52 | 8.12 | 7.46 | 8.05 | 230,312 | |
| 04/02/2024 | 7.60 | 7.68 | 7.30 | 7.48 | 229,792 | |
| 04/01/2024 | 7.22 | 7.77 | 7.10 | 7.72 | 209,435 | |
| 03/28/2024 | 7.27 | 7.46 | 7.10 | 7.25 | 267,314 | |
| 03/27/2024 | 7.47 | 7.61 | 7.28 | 7.34 | 131,092 | |
| 03/26/2024 | 7.22 | 7.52 | 7.16 | 7.36 | 198,622 | |
| 03/25/2024 | 7.53 | 7.68 | 7.34 | 7.40 | 167,610 | |
| 03/22/2024 | 7.48 | 7.83 | 7.45 | 7.61 | 171,392 | |
| 03/21/2024 | 7.57 | 7.74 | 7.27 | 7.53 | 316,806 | |
| 03/20/2024 | 7.52 | 7.74 | 7.41 | 7.53 | 370,899 | |
| 03/19/2024 | 7.00 | 7.67 | 6.77 | 7.57 | 830,333 | |
| 03/18/2024 | 7.90 | 7.94 | 6.65 | 6.99 | 1,397,515 | |
| 03/15/2024 | 8.11 | 8.87 | 8.03 | 8.63 | 462,219 | |
| 03/14/2024 | 8.18 | 8.38 | 7.96 | 8.14 | 212,713 | |
| 03/13/2024 | 8.20 | 8.40 | 7.80 | 8.23 | 251,951 | |
| 03/12/2024 | 7.72 | 8.48 | 7.40 | 8.18 | 478,884 | |
| 03/11/2024 | 7.88 | 8.11 | 7.72 | 7.81 | 405,175 | |
| 03/08/2024 | 8.39 | 8.40 | 7.84 | 7.97 | 262,604 | |
| 03/07/2024 | 8.70 | 8.81 | 8.19 | 8.25 | 425,693 | |
| 03/06/2024 | 8.57 | 9.01 | 8.12 | 8.68 | 406,952 | |
| 03/05/2024 | 7.74 | 8.70 | 7.60 | 8.46 | 484,244 | |
| 03/04/2024 | 7.95 | 8.24 | 7.45 | 7.81 | 498,179 | |
| 03/01/2024 | 7.00 | 7.87 | 6.92 | 7.81 | 1,159,770 | |
| 02/29/2024 | 6.96 | 7.11 | 6.67 | 6.90 | 251,125 | |
| 02/28/2024 | 7.30 | 7.32 | 6.87 | 6.90 | 330,864 | |
| 02/27/2024 | 7.54 | 7.87 | 7.08 | 7.35 | 623,209 | |
| 02/26/2024 | 7.00 | 7.70 | 6.94 | 7.54 | 637,825 | |
| 02/23/2024 | 6.70 | 6.98 | 6.60 | 6.98 | 242,904 | |
| 02/22/2024 | 6.79 | 6.99 | 6.61 | 6.70 | 241,434 | |
| 02/21/2024 | 6.69 | 6.95 | 6.48 | 6.75 | 212,835 | |
| 02/20/2024 | 7.10 | 7.50 | 6.16 | 6.74 | 477,041 | |
| 02/16/2024 | 6.49 | 7.03 | 6.49 | 7.01 | 314,348 | |
| 02/15/2024 | 6.10 | 6.53 | 5.99 | 6.49 | 232,872 | |
| 02/14/2024 | 6.44 | 6.44 | 5.84 | 6.15 | 406,500 | |
| 02/13/2024 | 6.30 | 7.03 | 6.12 | 6.31 | 508,107 | |
| 02/12/2024 | 6.21 | 6.52 | 6.03 | 6.48 | 497,361 | |
| 02/09/2024 | 5.28 | 6.33 | 5.28 | 6.20 | 832,495 | |
| 02/08/2024 | 5.01 | 5.45 | 4.97 | 5.28 | 377,279 | |
| 02/07/2024 | 4.53 | 5.04 | 4.40 | 4.90 | 459,355 | |
| 02/06/2024 | 4.25 | 4.41 | 4.25 | 4.30 | 126,646 | |
| 02/05/2024 | 4.42 | 4.49 | 4.25 | 4.29 | 94,803 | |
| 02/02/2024 | 4.24 | 4.47 | 4.13 | 4.42 | 160,654 | |
| 02/01/2024 | 4.35 | 4.45 | 4.03 | 4.30 | 455,727 | |
| 01/31/2024 | 4.45 | 4.57 | 4.02 | 4.07 | 1,057,456 | |
| 01/30/2024 | 4.85 | 4.94 | 4.45 | 4.48 | 547,460 | |
| 01/29/2024 | 4.65 | 4.95 | 4.65 | 4.85 | 65,620 | |
| 01/26/2024 | 4.75 | 4.76 | 4.56 | 4.69 | 112,686 | |
| 01/25/2024 | 4.76 | 4.82 | 4.73 | 4.76 | 67,999 | |
| 01/24/2024 | 4.89 | 4.95 | 4.73 | 4.76 | 95,779 |
About Abeona Therapeutics Stock history
Abeona Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Abeona is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Abeona Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Abeona Therapeutics stock prices may prove useful in developing a viable investing in Abeona Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 21.4 M | 22.4 M | |
| Net Loss | -39.1 M | -41.1 M |
Abeona Therapeutics Quarterly Net Working Capital |
|
Abeona Therapeutics Stock Technical Analysis
Abeona Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Abeona Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Abeona Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Abeona Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Abeona to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0879 | |||
| Jensen Alpha | 0.6028 | |||
| Total Risk Alpha | 0.1749 | |||
| Sortino Ratio | 0.1298 | |||
| Treynor Ratio | 0.3971 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abeona Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Abeona Stock, please use our How to Invest in Abeona Therapeutics guide.Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Abeona Stock analysis
When running Abeona Therapeutics' price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.53) | Revenue Per Share 0.164 | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (2.61) |
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abeona Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.